Life sciences leaders are feeling a mix of hope and worry as they look ahead to 2026. A recent survey shows that their optimism has dropped by 9% compared to last year. They are facing tough times in the money markets, changing political and regulatory environments, and cybersecurity threats. The s
The University of Luxembourg's Faculty of Law, Economics and Finance (FDEF) is facing serious trouble. Staff members, both past and present, have come forward with claims of a toxic work environment and unfair practices. Several court cases and internal complaints paint a picture of mismanagement an
Coinbase is stepping into the prediction market arena, but not everyone is convinced it's a winning move. Analysts from Mizuho have raised some red flags, suggesting that this new venture might not be as profitable as hoped. They worry that Coinbase users might start selling their crypto to fund the
Doctolib, a major player in the health tech world, is in talks to secure a massive secondary investment. This deal, potentially worth hundreds of millions, could see Generation Investment Management snag a piece of the company from current shareholders. Doctolib's last big funding round in 2022 saw
Robert F. Kennedy Jr. is in charge of the Department of Health and Human Services. He has a big platform to talk to Americans. But he says he doesn't want to give medical advice. That's different from what he said before. He once wanted to push people to exercise more. He even said parents should ma
Online studies are a big deal these days. They make research easier and faster. But there's a catch. Not everyone joins these studies. Some people are more likely to volunteer than others. This can cause a problem called volunteer bias. It can make the results of the study less accurate. A recent s
Hair turning gray is a natural part of aging, but not everyone goes gray at the same time. This is because the process is influenced by a mix of factors, including genetics, lifestyle, and even stress. The cells responsible for hair color, called melanocyte stem cells, start to slow down or stop wo
Dogecoin (DOGE) and Shiba Inu (SHIB) are having a rough day, both down by 3%. But while these old-school meme coins struggle, a new player is making waves. Fartcoin (FARTCOIN) is showing some serious potential, with charts hinting at a massive 400% rally by 2026. Let's talk about DOGE first. It's b
The FDA has recently given the green light to a wider group of women to use Addyi, a drug designed to boost sexual desire. This time, the approval is for postmenopausal women up to 65 years old. Addyi was first introduced a decade ago for premenopausal women dealing with emotional stress due to a lo
Cancer treatment just got a boost with a new tool that combines imaging and therapy. This tool, called NO2/BDP-BT, is designed to target cancer cells precisely. It works by using a special kind of light to kill cancer cells and monitor how well it's working. This is a big deal because traditional me
